Pular para o conteúdo
Paraplegia espástica hereditária complexa
ORPHA:102013DOENÇA RARA
Esta doença tem causa genética. Recomendamos procurar um médico geneticista para diagnóstico, exames genéticos e aconselhamento familiar.
Sistema ósseo
Também conhecida comoHSPSPG
Sinônimos clínicos: Paraparésia espástica familiar forma complexa

É uma condição genética que causa rigidez e fraqueza nas pernas, e que faz parte de um conjunto mais amplo de problemas de saúde.

Em construçãohistóricoSugerir correção
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

💬
EM LINGUAGEM SIMPLES

A Paraplegia espástica hereditária complexa é uma condição genética que provoca fraqueza e rigidez nos membros inferiores associadas a um conjunto mais amplo de alterações neurológicas. A família costuma perceber dificuldades progressivas para andar, alterações no equilíbrio, contrações musculares involuntárias e, em alguns casos, problemas de fala, visão ou controle da bexiga. O diagnóstico é auxiliado por exames neurológicos detalhados e pela realização de testes genéticos para identificar variantes moleculares. No Brasil, esta condição não consta na lista oficial de PCDTs de doenças raras do Ministério da Saúde, sendo o cuidado conduzido pela rede assistencial especializada do SUS.

📋
Informacoes curadas por IA — podem conter imprecisoes

É uma condição genética que causa rigidez e fraqueza nas pernas, e que faz parte de um conjunto mais amplo de problemas de saúde.

Publicações científicas
63 artigos
Último publicado: 2025 Dec 22
🏥
SUS: Sem cobertura SUSScore: 0%
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
106 sintomas
🦴
Ossos e articulações
52 sintomas
💪
Músculos
44 sintomas
👁️
Olhos
38 sintomas
😀
Face
23 sintomas
🫘
Rins
14 sintomas

+ 215 sintomas em outras categorias

Características mais comuns

—
Morfologia anormal da substância branca cerebral
—
Artralgia
—
Fraturas recorrentes
—
Fasciculações de membro
—
Fasciculações da língua
—
Aumento da densidade óssea espinhal
547sintomas
Sem dados (547)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 547 características clínicas mais associadas, ordenadas por frequência.

Morfologia anormal da substância branca cerebralAbnormal cerebral white matter morphology
ArtralgiaArthralgia
Fraturas recorrentesRecurrent fractures
Fasciculações de membroLimb fasciculations
Fasciculações da línguaTongue fasciculations

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2025
Total histórico63PubMed
Últimos 10 anos53publicações
Pico20229 papers
Linha do tempo
2025Hoje · 2026📈 2022Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

47 genes identificados com associação a esta condição.

Curadoria gene-doença

fontes oficiais
B4GALNT1 ENTPD1 MAG NT5C2 GBA2
B4GALNT1 ENTPD1 MAG NT5C2 GBA2
KIF1CKinesin-like protein KIF1CDisease-causing germline mutation(s) inRestrito
VIAS BIOLÓGICAS (2)
KinesinsCOPI-dependent Golgi-to-ER retrograde traffic
MECANISMO DE DOENÇA

Spastic ataxia 2, autosomal recessive

A neurologic disorder characterized by cerebellar ataxia, dysarthria, and variable spasticity of the lower limbs. Cognition is not affected.

EXPRESSÃO TECIDUAL(Ubíquo)
Músculo esquelético
308.2 TPM
Brain Spinal cord cervical c-1
252.4 TPM
Substância negra
164.6 TPM
Artéria tibial
160.2 TPM
Aorta
151.4 TPM
OUTRAS DOENÇAS (1)
spastic ataxia 2
HGNC:6317UniProt:O43896
USP8Ubiquitin carboxyl-terminal hydrolase 8Candidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (4)
Downregulation of ERBB2:ERBB3 signalingRegulation of FZD by ubiquitinationNegative regulation of MET activityUb-specific processing proteases
MECANISMO DE DOENÇA

Pituitary adenoma 4, ACTH-secreting

A form of pituitary adenoma, a neoplasm of the pituitary gland and one of the most common neuroendocrine tumors. Pituitary adenomas are clinically classified as functional and non-functional tumors, and manifest with a variety of features, including local invasion of surrounding structures and excessive hormone secretion. Functional pituitary adenomas are further classified by the type of hormone they secrete. PITA4 results in excessive production of adrenocorticotropic hormone. This leads to hypersecretion of cortisol by the adrenal glands and ACTH-dependent Cushing syndrome. Clinical manifestations of Cushing syndrome include facial and truncal obesity, abdominal striae, muscular weakness, osteoporosis, arterial hypertension, diabetes.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
10.4 TPM
Linfócitos
9.2 TPM
Nervo tibial
9.1 TPM
Cervix Endocervix
8.7 TPM
Ovário
8.3 TPM
OUTRAS DOENÇAS (2)
Cushing disease due to pituitary adenomaautosomal recessive spastic paraplegia type 59
HGNC:12631UniProt:P40818
ARSIArylsulfatase ICandidate gene tested inTolerante
VIAS BIOLÓGICAS (2)
The activation of arylsulfatasesGlycosphingolipid catabolism
INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (1)
autosomal recessive spastic paraplegia type 66
HGNC:32521UniProt:Q5FYB1
WDR48WD repeat-containing protein 48Candidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (3)
Fanconi Anemia PathwayRecognition of DNA damage by PCNA-containing replication complexUb-specific processing proteases
EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
41.7 TPM
Cérebro - Hemisfério cerebelar
28.1 TPM
Cervix Ectocervix
26.2 TPM
Cervix Endocervix
26.0 TPM
Cerebelo
25.8 TPM
OUTRAS DOENÇAS (1)
autosomal recessive spastic paraplegia type 60
HGNC:30914UniProt:Q8TAF3
MT-ATP6ATP synthase F(0) complex subunit aCandidate gene tested inDesconhecido
VIAS BIOLÓGICAS (4)
Mitochondrial translation terminationFormation of ATP by chemiosmotic couplingCristae formationMitochondrial protein degradation
MECANISMO DE DOENÇA

Neuropathy, ataxia, and retinitis pigmentosa

A syndrome characterized by variable combination of developmental delay, psychomotor retardation, hearing loss, optic atrophy and retinitis pigmentosa, dementia, seizures, ataxia, proximal neurogenic muscle weakness, and sensory neuropathy.

OUTRAS DOENÇAS (8)
mitochondrial diseasematernally-inherited Leigh syndromefamilial infantile bilateral striatal necrosismitochondrial proton-transporting ATP synthase complex deficiency
HGNC:7414UniProt:P00846
KYKyphoscoliosis peptidaseCandidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
E3 ubiquitin ligases ubiquitinate target proteins
MECANISMO DE DOENÇA

Myopathy, myofibrillar, 7

A form of myofibrillar myopathy, a group of chronic neuromuscular disorders characterized at ultrastructural level by disintegration of the sarcomeric Z disk and myofibrils, and replacement of the normal myofibrillar markings by small dense granules, or larger hyaline masses, or amorphous material. MFM7 is an autosomal recessive form, clinically characterized by early childhood onset of slowly progressive muscle weakness and mild atrophy primarily affecting the lower limbs, associated with joint contractures.

EXPRESSÃO TECIDUAL(Tecido-específico)
Skin Not Sun Exposed Suprapubic
8.7 TPM
Skin Sun Exposed Lower leg
6.8 TPM
Pituitária
6.4 TPM
Glândula adrenal
3.9 TPM
Fallopian Tube
3.7 TPM
INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (3)
myofibrillar myopathy 7kyphosis-lateral tongue atrophy-myofibrillar myopathy syndromekyphoscoliosis-lateral tongue atrophy-hereditary spastic paraplegia syndrome
HGNC:26576UniProt:Q8NBH2
FA2HFatty acid 2-hydroxylaseCandidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
Sphingolipid de novo biosynthesis
MECANISMO DE DOENÇA

Spastic paraplegia 35, autosomal recessive, with or without neurodegeneration

A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. SPG35 is a complicated form characterized by childhood onset of gait difficulties. It has a rapid progression and many patients become wheelchair-bound as young adults. Patients manifest cognitive decline associated with leukodystrophy. Other variable neurologic features, such as dystonia, optic atrophy, and seizures may also occur.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Spinal cord cervical c-1
209.6 TPM
Nervo tibial
76.1 TPM
Substância negra
42.8 TPM
Hipocampo
35.9 TPM
Estômago
35.7 TPM
OUTRAS DOENÇAS (2)
hereditary spastic paraplegia 35fatty acid hydroxylase-associated neurodegeneration
HGNC:21197UniProt:Q7L5A8
RAB3GAP2Rab3 GTPase-activating protein non-catalytic subunitCandidate gene tested inRestrito
VIAS BIOLÓGICAS (1)
RAB GEFs exchange GTP for GDP on RABs
MECANISMO DE DOENÇA

Martsolf syndrome 1

An autosomal recessive disease characterized by congenital cataracts, intellectual disability, and hypogonadism.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
30.9 TPM
Fibroblastos
20.4 TPM
Nervo tibial
16.4 TPM
Cérebro - Hemisfério cerebelar
15.7 TPM
Artéria tibial
15.5 TPM
OUTRAS DOENÇAS (4)
Warburg micro syndrome 2Martsolf syndrome 1autosomal recessive spastic paraplegia type 69Warburg micro syndrome
HGNC:17168UniProt:Q9H2M9
SELENOIEthanolaminephosphotransferase 1Candidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
Synthesis of PE
MECANISMO DE DOENÇA

Spastic paraplegia 81, autosomal recessive

A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. SPG81 is a complicated form characterized by white matter abnormalities, hypomyelination with progressive white matter loss, delayed motor development, progressive spasticity, and impaired intellectual development and speech delay. Additional features may include bifid uvula, microcephaly, seizures, and variable ocular anomalies.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
28.6 TPM
Skin Not Sun Exposed Suprapubic
23.1 TPM
Skin Sun Exposed Lower leg
22.1 TPM
Cerebelo
19.0 TPM
Linfócitos
17.6 TPM
OUTRAS DOENÇAS (2)
spastic paraplegia 81, autosomal recessiveautosomal recessive complex spastic paraplegia due to kennedy pathway dysfunction
HGNC:29361UniProt:Q9C0D9
PGAP1GPI inositol-deacylaseCandidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
Attachment of GPI anchor to uPAR
MECANISMO DE DOENÇA

Neurodevelopmental disorder with dysmorphic features, spasticity, and brain abnormalities

An autosomal recessive disorder characterized by severely delayed global development, with hypotonia, impaired intellectual development, and poor or absent speech. Most patients have spasticity with limb hypertonia and brisk tendon reflexes. Additional features include non-specific dysmorphic facial features, structural brain abnormalities, and cortical visual impairment.

EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
15.2 TPM
Cérebro - Hemisfério cerebelar
12.8 TPM
Cerebelo
12.7 TPM
Skin Not Sun Exposed Suprapubic
12.1 TPM
Skin Sun Exposed Lower leg
10.1 TPM
OUTRAS DOENÇAS (3)
intellectual disability, autosomal recessive 42autosomal recessive spastic paraplegia type 67autosomal recessive non-syndromic intellectual disability
HGNC:25712UniProt:Q75T13
ERLIN2Erlin-2Candidate gene tested inTolerante
VIAS BIOLÓGICAS (3)
AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274)ABC-family proteins mediated transportDefective CFTR causes cystic fibrosis
MECANISMO DE DOENÇA

Spastic paraplegia 18B, autosomal recessive

A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. SPG18B is a severe form with onset in early childhood. Most affected individuals have severe psychomotor retardation. Some may develop significant joint contractures.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
29.8 TPM
Tireoide
22.2 TPM
Ovário
21.0 TPM
Útero
18.9 TPM
Nervo tibial
18.8 TPM
OUTRAS DOENÇAS (4)
spastic paraplegia 18a, autosomal dominantjuvenile primary lateral sclerosishereditary spastic paraplegia 18recessive intellectual disability-motor dysfunction-multiple joint contractures syndrome
HGNC:1356UniProt:O94905
FLRT1Leucine-rich repeat transmembrane protein FLRT1Candidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
Downstream signaling of activated FGFR1
EXPRESSÃO TECIDUAL(Ubíquo)
Cervix Endocervix
7.6 TPM
Cerebelo
7.2 TPM
Cérebro - Hemisfério cerebelar
6.7 TPM
Córtex cerebral
6.7 TPM
Cólon sigmoide
6.5 TPM
OUTRAS DOENÇAS (1)
spastic paraplegia, optic atropy, and neuropathy
HGNC:3760UniProt:Q9NZU1
VCPTransitional endoplasmic reticulum ATPaseCandidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (10)
AggrephagyAttachment and EntryAttachment and EntryAMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274)ABC-family proteins mediated transport
MECANISMO DE DOENÇA

Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1

An autosomal dominant disease characterized by disabling muscle weakness clinically resembling to limb girdle muscular dystrophy, osteolytic bone lesions consistent with Paget disease, and premature frontotemporal dementia. Clinical features show incomplete penetrance.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
229.2 TPM
Linfócitos
209.1 TPM
Músculo esquelético
193.2 TPM
Aorta
172.4 TPM
Útero
171.2 TPM
OUTRAS DOENÇAS (10)
frontotemporal dementia and/or amyotrophic lateral sclerosis 6inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1Charcot-Marie-Tooth disease type 2Yamyotrophic lateral sclerosis
HGNC:12666UniProt:P55072
HACE1E3 ubiquitin-protein ligase HACE1Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Antigen processing: Ubiquitination & Proteasome degradation
EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
24.8 TPM
Cerebelo
23.5 TPM
Cervix Ectocervix
16.4 TPM
Nervo tibial
15.5 TPM
Cervix Endocervix
14.8 TPM
INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (2)
spastic paraplegia-severe developmental delay-epilepsy syndromeneuroblastoma
HGNC:21033UniProt:Q8IYU2
ATP13A2Polyamine-transporting ATPase 13A2Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Ion transport by P-type ATPases
MECANISMO DE DOENÇA

Kufor-Rakeb syndrome

A rare form of autosomal recessive juvenile or early-onset, levodopa-responsive parkinsonism. In addition to typical parkinsonian signs, clinical manifestations of Kufor-Rakeb syndrome include behavioral problems, facial tremor, pyramidal tract dysfunction, supranuclear gaze palsy, and dementia.

OUTRAS DOENÇAS (3)
Kufor-Rakeb syndromeautosomal recessive spastic paraplegia type 78parkinsonism due to ATP13A2 deficiency
HGNC:30213UniProt:Q9NQ11
SPG11SpatacsinDisease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Spastic paraplegia 11, autosomal recessive

A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
33.0 TPM
Tireoide
29.3 TPM
Baço
26.6 TPM
Fibroblastos
23.3 TPM
Pulmão
22.7 TPM
OUTRAS DOENÇAS (4)
amyotrophic lateral sclerosis type 5Charcot-Marie-Tooth disease axonal type 2Xhereditary spastic paraplegia 11juvenile amyotrophic lateral sclerosis
HGNC:11226UniProt:Q96JI7
AMPD2AMP deaminase 2Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Purine salvage
MECANISMO DE DOENÇA

Pontocerebellar hypoplasia 9

A form of pontocerebellar hypoplasia, a disorder characterized by structural defects of the pons and cerebellum, evident upon brain imaging. PCH9 features include severely delayed psychomotor development, progressive microcephaly, spasticity, seizures, and brain abnormalities, including brain atrophy, thin corpus callosum, and delayed myelination.

VIAS REACTOME (1)
OUTRAS DOENÇAS (2)
hereditary spastic paraplegia 63pontocerebellar hypoplasia type 9
HGNC:469UniProt:Q01433
GJC2Gap junction gamma-2 proteinDisease-causing germline mutation(s) inDesconhecido
VIAS BIOLÓGICAS (1)
Gap junction assembly
MECANISMO DE DOENÇA

Leukodystrophy, hypomyelinating, 2

An autosomal recessive hypomyelinating leukodystrophy with symptoms of Pelizaeus-Merzbacher disease. Clinically characterized by nystagmus, impaired motor development, ataxia, choreoathetotic movements, dysarthria, and progressive spasticity.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Brain Spinal cord cervical c-1
83.4 TPM
Substância negra
19.4 TPM
Útero
15.3 TPM
Fallopian Tube
13.9 TPM
Hipocampo
13.8 TPM
OUTRAS DOENÇAS (4)
hypomyelinating leukodystrophy 2lymphatic malformation 3hereditary spastic paraplegia 44GJC2-related late-onset primary lymphedema
HGNC:17494UniProt:Q5T442
CCT5T-complex protein 1 subunit epsilonDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (6)
Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta foldingAssociation of TriC/CCT with target proteins during biosynthesisPrefoldin mediated transfer of substrate to CCT/TriCFolding of actin by CCT/TriCFormation of tubulin folding intermediates by CCT/TriC
MECANISMO DE DOENÇA

Neuropathy, hereditary sensory, with spastic paraplegia, autosomal recessive

A disease characterized by spastic paraplegia and progressive distal sensory neuropathy leading to mutilating ulcerations of the upper and lower limbs.

OUTRAS DOENÇAS (1)
hereditary sensory and autonomic neuropathy with spastic paraplegia
HGNC:1618UniProt:P48643
IBA57Iron-sulfur cluster assembly factor IBA57, mitochondrialDisease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Multiple mitochondrial dysfunctions syndrome 3

A severe disorder of systemic energy metabolism, resulting in weakness, respiratory failure, lack of neurologic development, lactic acidosis, hyperglycinemia and early death. Some patients show failure to thrive, pulmonary hypertension, hypotonia and irritability. Biochemical features include severe combined deficiency of the 2-oxoacid dehydrogenases, defective lipoic acid synthesis and reduction in activity of mitochondrial respiratory chain complexes.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
9.4 TPM
Cérebro - Hemisfério cerebelar
4.7 TPM
Cerebelo
4.4 TPM
Útero
4.3 TPM
Ovário
4.1 TPM
OUTRAS DOENÇAS (2)
multiple mitochondrial dysfunctions syndrome 3hereditary spastic paraplegia 74
HGNC:27302UniProt:Q5T440
C19orf12Protein C19orf12Disease-causing germline mutation(s) inModerado
MECANISMO DE DOENÇA

Neurodegeneration with brain iron accumulation 4

A neurodegenerative disorder associated with iron accumulation in the brain, primarily in the basal ganglia. NBIA4 results in speech difficulty, extrapyramidal signs, oromandibular and generalized dystonia, and parkinsonism. Most patients have progressive involvement of the corticospinal tract, with spasticity, hyperreflexia, and extensor plantar responses.

OUTRAS DOENÇAS (2)
neurodegeneration with brain iron accumulation 4hereditary spastic paraplegia 43
HGNC:HGNC:25443UniProt:Q9NSK7
TFGProtein TFGDisease-causing germline mutation(s) inModerado
VIAS BIOLÓGICAS (1)
COPII-mediated vesicle transport
EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
86.6 TPM
Linfócitos
61.6 TPM
Tireoide
60.1 TPM
Nervo tibial
55.3 TPM
Aorta
53.8 TPM
OUTRAS DOENÇAS (5)
hereditary motor and sensory neuropathy, Okinawa typehereditary spastic paraplegia 57autosomal dominant Charcot-Marie-Tooth disease type 2 due to TFG mutationdifferentiated thyroid carcinoma
HGNC:11758UniProt:Q92734
ABHD16APhosphatidylserine lipase ABHD16ADisease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Spastic paraplegia 86, autosomal recessive

A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. SPG86 is an autosomal recessive form associated with impaired intellectual development, poor or absent speech, and behavioral abnormalities. Brain imaging shows thin corpus callosum and white matter abnormalities. Rare patients may have seizures.

OUTRAS DOENÇAS (1)
spastic paraplegia 86, autosomal recessive
HGNC:13921UniProt:O95870
MARS1Methionine--tRNA ligase, cytoplasmicDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (3)
Selenoamino acid metabolismCytosolic tRNA aminoacylationTranscriptional and post-translational regulation of MITF-M expression and activity
MECANISMO DE DOENÇA

Interstitial lung and liver disease

An autosomal recessive, life-threatening disorder characterized by respiratory insufficiency and progressive liver disease with onset in infancy or early childhood. Clinical features include failure to thrive, hypotonia, intermittent lactic acidosis, aminoaciduria, hypothyroidism, interstitial lung disease, pulmonary alveolar proteinosis, anemia, and liver canalicular cholestasis, steatosis, and iron deposition.

OUTRAS DOENÇAS (4)
severe early-onset pulmonary alveolar proteinosis due to MARS deficiencyautosomal recessive spastic paraplegia type 70Charcot-Marie-Tooth disease axonal type 2Utrichothiodystrophy 9, nonphotosensitive
HGNC:6898UniProt:P56192
VPS37AVacuolar protein sorting-associated protein 37ADisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (5)
Late endosomal microautophagyHCMV Late EventsMembrane binding and targetting of GAG proteinsBudding and maturation of HIV virionEndosomal Sorting Complex Required For Transport (ESCRT)
MECANISMO DE DOENÇA

Spastic paraplegia 53, autosomal recessive

A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. Complicated forms are recognized by additional variable features including spastic quadriparesis, seizures, dementia, amyotrophy, extrapyramidal disturbance, cerebral or cerebellar atrophy, optic atrophy, and peripheral neuropathy, as well as by extra neurological manifestations. SPG53 is characterized by pronounced early onset spastic paraparesis of upper and lower limbs, mild intellectual disability, kyphosis, pectus carinatum and hypertrichosis.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
25.3 TPM
Testículo
22.8 TPM
Artéria tibial
21.1 TPM
Fibroblastos
20.5 TPM
Cerebelo
20.3 TPM
OUTRAS DOENÇAS (1)
hereditary spastic paraplegia 53
HGNC:24928UniProt:Q8NEZ2
KLC2Kinesin light chain 2Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (4)
RHO GTPases activate KTN1KinesinsCOPI-dependent Golgi-to-ER retrograde trafficMHC class II antigen presentation
MECANISMO DE DOENÇA

Spastic paraplegia, optic atrophy, and neuropathy

A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. SPOAN is characterized by spastic paraplegia with progressive joint contractures and spine deformities, loss of independent ambulation by age 10 years, sub-normal vision secondary to congenital optic atrophy, and neuropathy. Inheritance is autosomal recessive.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
185.1 TPM
Cerebelo
180.9 TPM
Brain Frontal Cortex BA9
83.9 TPM
Córtex cerebral
82.6 TPM
Pituitária
58.0 TPM
OUTRAS DOENÇAS (1)
spastic paraplegia, optic atropy, and neuropathy
HGNC:20716UniProt:Q9H0B6
MTRFRMitochondrial translation release factor in rescueDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Mitochondrial ribosome-associated quality control
MECANISMO DE DOENÇA

Combined oxidative phosphorylation deficiency 7

A mitochondrial disease resulting in encephalomyopathy. Clinical manifestations include psychomotor delay and regression, ataxia, optic atrophy, nystagmus and muscle atrophy and weakness.

OUTRAS DOENÇAS (2)
hereditary spastic paraplegia 55combined oxidative phosphorylation defect type 7
HGNC:26784UniProt:Q9H3J6
RNF170E3 ubiquitin-protein ligase RNF170Disease-causing germline mutation(s) inRestrito
MECANISMO DE DOENÇA

Ataxia, sensory, 1, autosomal dominant

A rare disease characterized by progressive ataxia caused by degeneration of the posterior columns of the spinal cord. Affected individuals have a reduced ability to feel pain, temperature and vibration, particularly in the hands and feet. Their most prominent feature is an ataxic gait resulting from a severe loss of proprioception. Thus, patients rely on visual cues for maintaining proper body posture, such that they are unable to remain upright if their eyes are closed (Romberg sign).

EXPRESSÃO TECIDUAL(Ubíquo)
Tireoide
25.5 TPM
Cérebro - Hemisfério cerebelar
21.4 TPM
Cerebelo
18.3 TPM
Brain Spinal cord cervical c-1
14.5 TPM
Nervo tibial
13.9 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (2)
spastic paraplegia 85, autosomal recessiveautosomal dominant sensory ataxia 1
HGNC:25358UniProt:Q96K19
MAGMyelin-associated glycoproteinDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (3)
Basigin interactionsAxonal growth inhibition (RHOA activation)EGR2 and SOX10-mediated initiation of Schwann cell myelination
MECANISMO DE DOENÇA

Spastic paraplegia 75, autosomal recessive

A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. SPG75 is characterized by onset in early childhood and is associated with mild to moderate cognitive impairment.

EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Spinal cord cervical c-1
839.0 TPM
Substância negra
181.8 TPM
Hipocampo
144.8 TPM
Brain Putamen basal ganglia
120.8 TPM
Brain Caudate basal ganglia
78.0 TPM
OUTRAS DOENÇAS (1)
hereditary spastic paraplegia 75
HGNC:6783UniProt:P20916
ENTPD1Ectonucleoside triphosphate diphosphohydrolase 1Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
Purinergic signaling in leishmaniasis infectionPhosphate bond hydrolysis by NTPDase proteins
MECANISMO DE DOENÇA

Spastic paraplegia 64, autosomal recessive

A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
158.7 TPM
Artéria tibial
71.3 TPM
Artéria coronária
45.0 TPM
Útero
41.3 TPM
Aorta
30.8 TPM
OUTRAS DOENÇAS (1)
hereditary spastic paraplegia 64
HGNC:3363UniProt:P49961
GBA2Non-lysosomal glucosylceramidaseDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Glycosphingolipid catabolism
MECANISMO DE DOENÇA

Spastic paraplegia 46, autosomal recessive

A neurodegenerative disorder characterized by onset in childhood of slowly progressive spastic paraplegia and cerebellar signs. Some patients have cognitive impairment, cataracts, and cerebral, cerebellar, and corpus callosum atrophy on brain imaging.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
137.0 TPM
Cérebro - Hemisfério cerebelar
119.2 TPM
Tireoide
100.6 TPM
Intestino delgado
98.6 TPM
Pituitária
87.5 TPM
OUTRAS DOENÇAS (2)
hereditary spastic paraplegia 46autosomal recessive cerebellar ataxia with late-onset spasticity
HGNC:18986UniProt:Q9HCG7
NT5C2Cytosolic purine 5'-nucleotidaseDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (3)
Purine catabolismRibavirin ADMEAbacavir metabolism
MECANISMO DE DOENÇA

Spastic paraplegia 45, autosomal recessive

A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. Some SPG45 patients manifest intellectual disability, contractures and learning disability.

EXPRESSÃO TECIDUAL(Ubíquo)
Tireoide
68.9 TPM
Esôfago - Mucosa
56.0 TPM
Glândula salivar
48.4 TPM
Fibroblastos
46.6 TPM
Artéria tibial
46.3 TPM
OUTRAS DOENÇAS (1)
hereditary spastic paraplegia 45
HGNC:8022UniProt:P49902
DSTYKDual serine/threonine and tyrosine protein kinaseDisease-causing germline mutation(s) inAltamente restrito
MECANISMO DE DOENÇA

Congenital anomalies of the kidney and urinary tract 1

A disorder encompassing a broad spectrum of renal and urinary tract malformations that include renal agenesis, kidney hypodysplasia, multicystic kidney dysplasia, duplex collecting system, posterior urethral valves and ureter abnormalities. Congenital anomalies of kidney and urinary tract are the commonest cause of chronic kidney disease in children.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
33.1 TPM
Cerebelo
25.4 TPM
Útero
16.7 TPM
Brain Frontal Cortex BA9
15.5 TPM
Ovário
14.8 TPM
OUTRAS DOENÇAS (3)
congenital anomalies of kidney and urinary tract 1hereditary spastic paraplegia 23renal agenesis, unilateral
HGNC:29043UniProt:Q6XUX3
GPT2Alanine aminotransferase 2Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Alanine metabolism
MECANISMO DE DOENÇA

Neurodevelopmental disorder with spastic paraplegia and microcephaly

An autosomal recessive syndrome characterized by severe psychomotor developmental delay, dysarthria, walking difficulties, moderately to severely impaired intellectual development, poor or absent speech, and progressive microcephaly.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Esôfago - Mucosa
93.0 TPM
Estômago
87.0 TPM
Fígado
65.7 TPM
Glândula salivar
61.2 TPM
Skin Not Sun Exposed Suprapubic
59.9 TPM
OUTRAS DOENÇAS (1)
glutamate pyruvate transaminase 2 deficiency
HGNC:18062UniProt:Q8TD30
ARL6IP1ADP-ribosylation factor-like protein 6-interacting protein 1Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Spastic paraplegia 61, autosomal recessive

A complicated form of spastic paraplegia with polysensory and motor neuropathy. Spastic paraplegia is a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body.

OUTRAS DOENÇAS (1)
hereditary spastic paraplegia 61
HGNC:697UniProt:Q15041
L1CAMNeural cell adhesion molecule L1Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (5)
Basigin interactionsRecycling pathway of L1L1CAM interactionsSignal transduction by L1Interaction between L1 and Ankyrins
MECANISMO DE DOENÇA

Hydrocephalus, congenital, X-linked

An X-linked recessive form of congenital hydrocephalus, a disease characterized by in utero onset of enlarged ventricles due to accumulation of ventricular cerebrospinal fluid. HYCX is the most common inherited form and occurs in approximately 1/30000 male births. The primary diagnostic criteria of intellectual disability and enlarged cerebral ventricles are often accompanied by spastic paraparesis and adducted thumbs and, occasionally, visual defects or seizures. The most severe cases die pre- or perinatally with gross hydrocephalus and enlarged head circumference. Stenosis of the aqueduct of Sylvius is frequently associated with the disorder.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
258.9 TPM
Cérebro - Hemisfério cerebelar
236.4 TPM
Nervo tibial
112.8 TPM
Córtex cerebral
69.3 TPM
Brain Frontal Cortex BA9
67.7 TPM
OUTRAS DOENÇAS (4)
MASA syndromeX-linked complicated corpus callosum dysgenesisX-linked hydrocephalus with stenosis of the aqueduct of SylviusX-linked complicated spastic paraplegia type 1
HGNC:6470UniProt:P32004
KIDINS220Kinase D-interacting substrate of 220 kDaDisease-causing germline mutation(s) inRestrito
VIAS BIOLÓGICAS (3)
ARMS-mediated activationRND1 GTPase cycleRND2 GTPase cycle
MECANISMO DE DOENÇA

Spastic paraplegia, intellectual disability, nystagmus, and obesity

An autosomal dominant syndrome characterized by rapid growth in infancy, obesity, global developmental delay, intellectual disability, spastic paraplegia, ocular defects, and dysmorphic facial features.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
55.4 TPM
Cerebelo
40.8 TPM
Ovário
35.1 TPM
Útero
31.7 TPM
Nervo tibial
31.4 TPM
OUTRAS DOENÇAS (2)
spastic paraplegia, intellectual disability, nystagmus, and obesityventriculomegaly and arthrogryposis
HGNC:29508UniProt:Q9ULH0
PI4KAPhosphatidylinositol 4-kinase alphaDisease-causing germline mutation(s) inRestrito
VIAS BIOLÓGICAS (2)
Synthesis of PIPs at the Golgi membraneSynthesis of PIPs at the ER membrane
MECANISMO DE DOENÇA

Neurodevelopmental disorder with spasticity, hypomyelinating leukodystrophy, and brain abnormalities

A severe autosomal recessive disorder characterized by global developmental delay with impaired intellectual development and poor or absent speech, axial hypotonia, and peripheral spasticity and hyperreflexia. Brain imaging shows hypomyelination with decreased white matter volume, cerebral and cerebellar atrophy, and thin corpus callosum. Polymicrogyria may be observed in rare cases. Some patients have a primary immunodeficiency or gastrointestinal disturbances similar to inflammatory bowel disease.

EXPRESSÃO TECIDUAL(Ubíquo)
Córtex cerebral
113.3 TPM
Cerebelo
110.8 TPM
Cérebro - Hemisfério cerebelar
103.0 TPM
Brain Frontal Cortex BA9
100.3 TPM
Útero
66.4 TPM
OUTRAS DOENÇAS (5)
polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposisgastrointestinal defects and immunodeficiency syndrome 2spastic paraplegia 84, autosomal recessivebilateral perisylvian polymicrogyria
HGNC:8983UniProt:P42356
CAPN1Calpain-1 catalytic subunitDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (3)
Formation of the cornified envelopeDegradation of the extracellular matrixDeregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
MECANISMO DE DOENÇA

Spastic paraplegia 76, autosomal recessive

A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body.

OUTRAS DOENÇAS (1)
autosomal recessive spastic paraplegia type 76
HGNC:1476UniProt:P07384
DDHD2Triacylglycerol hydrolase DDHD2Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Synthesis of PA
MECANISMO DE DOENÇA

Spastic paraplegia 54, autosomal recessive

A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. Complicated forms are recognized by additional variable features including spastic quadriparesis, seizures, dementia, amyotrophy, extrapyramidal disturbance, cerebral or cerebellar atrophy, optic atrophy, and peripheral neuropathy, as well as by extra neurological manifestations. SPG54 patients have delayed psychomotor development, intellectual disability, and early-onset spasticity of the lower limbs. Brain MRI shows a thin corpus callosum and periventricular white matter lesions, and an abnormal lipid peak due to accumulation of neutral lipids in certain brain regions.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
52.8 TPM
Brain Spinal cord cervical c-1
43.3 TPM
Nervo tibial
40.4 TPM
Cerebelo
40.2 TPM
Ovário
35.3 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (1)
hereditary spastic paraplegia 54
HGNC:29106UniProt:O94830
ZFYVE26Zinc finger FYVE domain-containing protein 26Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Spastic paraplegia 15, autosomal recessive

A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. SPG15 is a complex form associated with additional neurological symptoms such as cognitive deterioration or intellectual disability, axonal neuropathy, mild cerebellar signs, and, less frequently, a central hearing deficit, decreased visual acuity, or retinal degeneration.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
16.0 TPM
Cérebro - Hemisfério cerebelar
14.9 TPM
Linfócitos
14.9 TPM
Nervo tibial
14.8 TPM
Ovário
13.9 TPM
OUTRAS DOENÇAS (1)
hereditary spastic paraplegia 15
HGNC:20761UniProt:Q68DK2
BSCL2SeipinDisease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Lipodystrophy, congenital generalized, 2

A form of congenital generalized lipodystrophy, a metabolic disorder characterized by a near complete absence of adipose tissue, extreme insulin resistance, hypertriglyceridemia, hepatic steatosis and early onset of diabetes. Inheritance is autosomal recessive.

OUTRAS DOENÇAS (5)
hereditary spastic paraplegia 17severe neurodegenerative syndrome with lipodystrophyneuronopathy, distal hereditary motor, type 5Ccongenital generalized lipodystrophy type 2
HGNC:15832UniProt:Q96G97
SPARTSpartinDisease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Spastic paraplegia 20, autosomal recessive

A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. SPG20 is characterized by dysarthria, distal amyotrophy, mild developmental delay and short stature.

OUTRAS DOENÇAS (1)
Troyer syndrome
HGNC:18514UniProt:Q8N0X7
PNPLA6Patatin-like phospholipase domain-containing protein 6Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Glycerophospholipid catabolism
MECANISMO DE DOENÇA

Spastic paraplegia 39, autosomal recessive

A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. SPG39 is associated with a motor axonopathy affecting upper and lower limbs and resulting in progressive wasting of distal upper and lower extremity muscles.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
75.4 TPM
Pulmão
74.4 TPM
Baço
65.5 TPM
Pituitária
51.6 TPM
Sangue
49.8 TPM
OUTRAS DOENÇAS (5)
hereditary spastic paraplegia 39trichomegaly-retina pigmentary degeneration-dwarfism syndromeataxia-hypogonadism-choroidal dystrophy syndromeLaurence-Moon syndrome
HGNC:16268UniProt:Q8IY17
B4GALNT1Beta-1,4 N-acetylgalactosaminyltransferase 1Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Glycosphingolipid biosynthesis
MECANISMO DE DOENÇA

Spastic paraplegia 26, autosomal recessive

A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. SPG26 is a complicated form characterized by onset in the first 2 decades of life of gait abnormalities due to lower limb spasticity and muscle weakness. Some patients have upper limb involvement. Additional features include intellectual disability, peripheral neuropathy, dysarthria, cerebellar signs, extrapyramidal signs, and cortical atrophy. The disorder is slowly progressive.

OUTRAS DOENÇAS (1)
hereditary spastic paraplegia 26
HGNC:4117UniProt:Q00973
ALDH18A1Delta-1-pyrroline-5-carboxylate synthaseDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Mitochondrial protein degradation
MECANISMO DE DOENÇA

Cutis laxa, autosomal recessive, 3A

A syndrome characterized by facial dysmorphism with a progeroid appearance, large and late-closing fontanel, cutis laxa, joint hyperlaxity, athetoid movements and hyperreflexia, pre- and postnatal growth retardation, intellectual deficit, developmental delay, and ophthalmologic abnormalities.

OUTRAS DOENÇAS (6)
hereditary spastic paraplegia 9Aautosomal recessive complex spastic paraplegia type 9Bcutis laxa, autosomal dominant 3ALDH18A1-related de Barsy syndrome
HGNC:9722UniProt:P54886
TECPR2Tectonin beta-propeller repeat-containing protein 2Disease-causing germline mutation(s) inRestrito
MECANISMO DE DOENÇA

Neuropathy, hereditary sensory and autonomic, 9, with developmental delay

A form of hereditary sensory and autonomic neuropathy, a genetically and clinically heterogeneous group of disorders characterized by degeneration of dorsal root and autonomic ganglion cells, and by sensory and/or autonomic abnormalities. HSAN9 is characterized by global developmental delay and intellectual disability, axial and appendicular hypotonia, dysarthria, and an abnormal gait that is often described as ataxic. Other features may include peripheral neuropathy, hyporeflexia, and autonomic dysfunction. Affected individuals also have dysmorphic features, thin corpus callosum on brain imaging, and episodes of central apnea, which may be fatal.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
25.5 TPM
Esôfago - Muscular
20.6 TPM
Sangue
19.8 TPM
Esôfago - Junção
19.7 TPM
Cerebelo
19.4 TPM
OUTRAS DOENÇAS (1)
hereditary spastic paraplegia 49
HGNC:19957UniProt:O15040

Variantes genéticas (ClinVar)

146 variantes patogênicas registradas no ClinVar.

🧬 KIF1C: NM_006612.6(KIF1C):c.1039C>T (p.Gln347Ter) ()
🧬 KIF1C: NM_006612.6(KIF1C):c.865-1G>A ()
🧬 KIF1C: NM_006612.6(KIF1C):c.1479C>G (p.Phe493Leu) ()
🧬 KIF1C: NM_006612.6(KIF1C):c.941-2A>G ()
🧬 KIF1C: NM_006612.6(KIF1C):c.64C>T (p.Gln22Ter) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 6 variantes classificadas pelo ClinVar.

6
Patogênica (100.0%)
VARIANTES MAIS SIGNIFICATIVAS
PRKN: GRCh37/hg19 6q26(chr6:162622080-162683770)x1 [Likely pathogenic]
SORL1: NM_003105.6(SORL1):c.1211+1G>A [Pathogenic]
ABHD16A: NM_021160.3(ABHD16A):c.340C>T (p.Arg114Ter) [Pathogenic]
ABHD16A: NM_021160.3(ABHD16A):c.1370G>A (p.Arg457Gln) [Pathogenic]
DSTYK: NM_015375.3(DSTYK):c.1384C>T (p.Arg462Ter) [Conflicting classifications of pathogenicity]

Vias biológicas (Reactome)

102 vias biológicas associadas aos genes desta condição.

COPI-dependent Golgi-to-ER retrograde traffic Kinesins Downregulation of ERBB2:ERBB3 signaling Regulation of FZD by ubiquitination Ub-specific processing proteases Negative regulation of MET activity The activation of arylsulfatases Glycosphingolipid catabolism Recognition of DNA damage by PCNA-containing replication complex Fanconi Anemia Pathway Signaling by cytosolic PDGFRA and PDGFRB fusion proteins Formation of ATP by chemiosmotic coupling Mitochondrial translation termination Cristae formation Mitochondrial protein degradation Transcriptional regulation by RUNX3 IRAK1 recruits IKK complex IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation Regulation of RUNX2 expression and activity Mitochondrial translation TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain Insertion of tail-anchored proteins into the endoplasmic reticulum membrane TP53 Regulates Transcription of Cell Death Genes Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models Sphingolipid de novo biosynthesis COPI-independent Golgi-to-ER retrograde traffic RAB GEFs exchange GTP for GDP on RABs Synthesis of PE Attachment of GPI anchor to uPAR ABC-family proteins mediated transport Signaling by FGFR1 in disease Defective CFTR causes cystic fibrosis Signaling by plasma membrane FGFR1 fusions AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) Downstream signaling of activated FGFR1 Translesion Synthesis by POLH HSF1 activation N-glycan trimming in the ER and Calnexin/Calreticulin cycle Hedgehog ligand biogenesis Hh mutants are degraded by ERAD Josephin domain DUBs Ovarian tumor domain proteases Neutrophil degranulation E3 ubiquitin ligases ubiquitinate target proteins Protein methylation Neddylation RHOH GTPase cycle Aggrephagy Attachment and Entry Attachment and Entry KEAP1-NFE2L2 pathway Dengue Virus Genome Translation and Replication Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide Antigen processing: Ubiquitination & Proteasome degradation Ion transport by P-type ATPases Purine salvage Gap junction assembly Prefoldin mediated transfer of substrate to CCT/TriC Formation of tubulin folding intermediates by CCT/TriC Folding of actin by CCT/TriC Association of TriC/CCT with target proteins during biosynthesis BBSome-mediated cargo-targeting to cilium Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding Mitochondrial iron-sulfur cluster biogenesis COPII-mediated vesicle transport Signaling by ALK fusions and activated point mutants Selenoamino acid metabolism Cytosolic tRNA aminoacylation Transcriptional and post-translational regulation of MITF-M expression and activity Budding and maturation of HIV virion Membrane binding and targetting of GAG proteins Endosomal Sorting Complex Required For Transport (ESCRT) HCMV Late Events Late endosomal microautophagy MHC class II antigen presentation RHO GTPases activate KTN1 Mitochondrial ribosome-associated quality control Axonal growth inhibition (RHOA activation) Basigin interactions EGR2 and SOX10-mediated initiation of Schwann cell myelination Phosphate bond hydrolysis by NTPDase proteins Purinergic signaling in leishmaniasis infection Abacavir metabolism Purine catabolism Ribavirin ADME Alanine metabolism L1CAM interactions Recycling pathway of L1 Interaction between L1 and Ankyrins Signal transduction by L1 ARMS-mediated activation RND2 GTPase cycle RND1 GTPase cycle Synthesis of PIPs at the ER membrane Synthesis of PIPs at the Golgi membrane Degradation of the extracellular matrix Formation of the cornified envelope Synthesis of PA Glycerophospholipid catabolism Glycosphingolipid biosynthesis Glutamate and glutamine metabolism

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Paraplegia espástica hereditária complexa

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
54 papers (10 anos)
#1

Swiss Cheese Gene Is Important for Intestinal Barrier, Microbiome, and Lipid Metabolism Regulation in Drosophila Gut.

International journal of molecular sciences2025 Nov 16

Mutations in the human patatin-like lysophospholipase domain containing the 6 gene PNPLA6 encode an evolutionarily conserved (lyso)phospholipase, leading to the development of a complex hereditary spastic paraplegia 39 (SPG 39) and a number of rare severe syndromes in humans. Diseases disrupt the functioning of the nervous and reproductive systems and the gastrointestinal tract. The study aims to investigate the role of the Drosophila melanogaster swiss cheese gene, an ortholog of the human PNPLA6 gene, in gut function. We showed that the swiss cheese gene knockout leads to changes in the morphology of the midgut, disruption of the septate junction structure and the intestinal barrier permeability, and a decrease in the lipid droplet number in enterocytes. As a result of such disturbances, intestinal stem cells (ISCs) proliferation is activated, and the gut microbiome is altered. Ectopic expression of human PNPLA6 leads to the recovery of the intestinal barrier in the fly gut. The example of Drosophila demonstrates the important role of evolutionarily conserved (lyso)phospholipase in intestinal homeostasis.

#2

Triglycerides are an important fuel reserve for synapse function in the brain.

Nature metabolism2025 Jul

Proper fuelling of the brain is critical to sustain cognitive function, but the role of fatty acid (FA) combustion in this process has been elusive. Here we show that acute block of a neuron-specific triglyceride lipase, DDHD2 (a genetic driver of complex hereditary spastic paraplegia), or of the mitochondrial lipid transporter CPT1 leads to rapid onset of torpor in adult male mice. These data indicate that in vivo neurons are probably constantly fluxing FAs derived from lipid droplets (LDs) through β-oxidation to support neuronal bioenergetics. We show that in dissociated neurons, electrical silencing or blocking of DDHD2 leads to accumulation of neuronal LDs, including at nerve terminals, and that FAs derived from axonal LDs enter mitochondria in an activity-dependent fashion to drive local mitochondrial ATP production. These data demonstrate that nerve terminals can make use of LDs during electrical activity to provide metabolic support and probably have a critical role in supporting neuron function in vivo.

#3

Altered tubulin detyrosination due to SVBP malfunction induces cytokinesis failure and senescence, underlying a complex hereditary spastic paraplegia.

Aging cell2025 Jan

Senescence, marked by permanent cell cycle arrest may contribute to the decline in regenerative potential and neuronal function, thereby promoting neurodegenerative disorders. In this study, we employed whole exome sequencing to identify a previously unreported biallelic missense variant in SVBP (p.Leu49Pro) in six patients from three unrelated families. These affected individuals present with a complex hereditary spastic paraplegia (HSP), peripheral neuropathy, verbal apraxia, and intellectual disability, exhibiting a milder phenotype compared to patients with nonsense SVBP mutations described previously. Consistent with SVBP's primary role as a chaperone necessary for VASH-mediated tubulin detyrosination, both patient fibroblasts with the p.Leu49Pro mutation, and HeLa cells harboring an SVBP knockdown exhibit microtubule dynamic instability and alterations in pericentriolar material (PCM) component trafficking and centrosome cohesion. In patient fibroblasts, structural abnormalities in the centrosome trigger mitotic errors and cellular senescence. Notably, premature senescence characterized by elevated levels of p16INK4, was also observed in patient peripheral blood mononuclear cells (PBMCs). Taken together, our findings underscore the critical role of SVBP in the development and maintenance of the central nervous system, providing novel insights associating cytokinesis failure with cortical motor neuron disease and intellectual disability.

#4

Expanding the clinical phenotype of DYNC1H1 -associated mutations: a Chinese family with autosomal dominant complex hereditary spastic paraplegia.

BMC medical genomics2025 Dec 22

Hereditary spastic paraplegias (HSPs) are a clinically and genetically heterogeneous group of neurodegenerative diseases. To date, at least 84 distinct loci (SPGs) and 67 causative genes have been identified. Even though the number of known causative genes is constantly increasing, a substantial portion of patients remains without a molecular diagnosis. Variants in the dynein, cytoplasmic 1, heavy chain 1(DYNC1H1)gene have been reported to cause a range of neurogenetic diseases, including spinal muscular atrophy (SMA), Charcot-Marie-Tooth disease (CMT), and cortical malformations. This study aims to characterize the clinical spectrum of DYNC1H1-related disorders by reporting a rare missense variant (c.13763 C > T, p.Thr4588Met) identified in a Chinese family with autosomal dominant (AD) complex HSP. The affected individuals underwent a comprehensive neurological evaluation, including assessment of clinical features, laboratory testing, brain magnetic resonance imaging (MRI), and electrophysiological studies. The repetition/deletions in the SPAST, ATL1 gene were detected using multiplex ligation-dependent probe analysis (MLPA). Whole-exome sequencing (WES) was performed to identify the disease-causing mutation in the proband, which was subsequently validated by Sanger sequencing in the proband and his parents. In silico analysis was performed to predict the pathogenicity of the identified mutations. A heterozygous missense variant (c.13763 C > T, p.Thr4588Met) in the DYNC1H1 gene was identified, which was classified as likely pathogenic according to ACMG guidelines. The family was affected by autosomal dominant complex HSP, presenting with marked spastic paraplegia and ataxia. In silico analyses (e.g., using PolyPhen-2, PROVEAN, Mutation Taster, and CADD) indicated a deleterious effect on protein function. This study reports a rare DYNC1H1 variant associated with autosomal dominant (AD) complex HSP, expanding the mutational and phenotypic spectrum of DYNC1H1-related disorders.

#5

Clinical characteristics and gene mutation analysis of a family with hereditary spastic paraplegia type 11: a case report.

Journal of medical case reports2025 Dec 01

Autosomal recessive hereditary spastic paraplegia with thinning of the corpus callosum is a complex hereditary spastic paraplegia. Spastic paraplegia type 11 (SPG11) mutation is the most frequent form of autosomal recessive hereditary spastic paraplegia with thinning of the corpus callosum. The study of SPG11 in China is small scale, and only a few gene mutations have been reported. We report the case of a family with autosomal recessive hereditary spastic paraplegia with thinning of the corpus callosum. We describe a 20-year-old Han female patient with spastic gait and cognitive impairment 2 years ago, whose brain imaging revealed a thinning corpus callosum. Her 14-year-old Han brother had only a spasmodic gait. Detailed history, physical examination, and supplementary examination were performed to rule out the cause of spastic paraplegia. To identify pathogenic mutations, we used target sequence capture sequencing technology to detect hereditary-spastic-paraplegia-related genes in family members in combination with Sanger sequencing. We found two new complex heterozygous mutations in SPG11: c.6738_6739insT and c.5934_5935insTAACCTGGAA. The Glu2247 amino acid codon was changed to a stop codon (p.Glu2247Ter), and the Val1979 amino acid was also changed to a stop codon (p. Val1979Ter). Bioinformatics analysis predicted that these mutations would result in a loss of protein function. In silico analysis of the mutant sequences was performed. We found two novel complex heterozygous mutations, c.6738_6739insT and c.5934_5935insTAACCTGGAA, which enriched the phenotypic spectrum of SPG11 mutations related to hereditary spastic paraplegia and may help to determine the molecular mechanism of hereditary spastic paraplegia with thinning of the corpus callosum.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC27 artigos no totalmostrando 51

2025

Expanding the clinical phenotype of DYNC1H1 -associated mutations: a Chinese family with autosomal dominant complex hereditary spastic paraplegia.

BMC medical genomics
2025

Clinical characteristics and gene mutation analysis of a family with hereditary spastic paraplegia type 11: a case report.

Journal of medical case reports
2025

Swiss Cheese Gene Is Important for Intestinal Barrier, Microbiome, and Lipid Metabolism Regulation in Drosophila Gut.

International journal of molecular sciences
2025

Triglycerides are an important fuel reserve for synapse function in the brain.

Nature metabolism
2025

FIC Domain Protein Adenylyltransferase (FICD)-Related Complex Hereditary Spastic Paraplegia with Diabetes Mellitus.

Movement disorders clinical practice
2025

Altered tubulin detyrosination due to SVBP malfunction induces cytokinesis failure and senescence, underlying a complex hereditary spastic paraplegia.

Aging cell
2025

Case Report of Friedreich's Ataxia and ALG1 -Related Biochemical Abnormalities in a Patient With Progressive Spastic Paraplegia.

American journal of medical genetics. Part A
2023

RINT1 deficiency disrupts lipid metabolism and underlies a complex hereditary spastic paraplegia.

The Journal of clinical investigation
2023

The Troyer syndrome protein spartin mediates selective autophagy of lipid droplets.

Nature cell biology
2023

Biallelic DDHD2 mutations in patients with adult-onset complex hereditary spastic paraplegia.

Annals of clinical and translational neurology
2023

Early-Onset and Severe Complex Hereditary Spastic Paraplegia Caused by De Novo Variants in SPAST.

Movement disorders : official journal of the Movement Disorder Society
2023

Cation leak through the ATP1A3 pump causes spasticity and intellectual disability.

Brain : a journal of neurology
2023

SPTSSA variants alter sphingolipid synthesis and cause a complex hereditary spastic paraplegia.

Brain : a journal of neurology
2022

Phenotypic continuum of NFU1-related disorders.

Annals of clinical and translational neurology
2022

Case report: Novel compound heterozygous missense mutations in the DDHD2 gene in a Chinese patient associated with spastic paraplegia type 54.

Frontiers in pediatrics
2022

Infantile-Onset Complex Hereditary Spastic Paraplegia Due to a Novel Mutation in SPAST Gene.

Pediatric neurology
2022

Functional validation of novel variants in B4GALNT1 associated with early-onset complex hereditary spastic paraplegia with impaired ganglioside synthesis.

American journal of medical genetics. Part A
2023

A homozygous variant in CHMP3 is associated with complex hereditary spastic paraplegia.

Journal of medical genetics
2022

Novel CAPN1 missense variants in complex hereditary spastic paraplegia with early-onset psychosis.

Annals of clinical and translational neurology
2022

Interacting with AP1 complex mutated synergin gamma (SYNRG) reveals a novel coatopathy in the form of complicated hereditary spastic paraplegia.

Brain & development
2022

A homozygous ABHD16A variant causes a complex hereditary spastic paraplegia with developmental delay, absent speech, and characteristic face.

Clinical genetics
2021

SPG6 (NIPA1 variant): A report of a case with early-onset complex hereditary spastic paraplegia and brief literature review.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
2022

Heterozygous De Novo KPNA3 Mutations Cause Complex Hereditary Spastic Paraplegia.

Annals of neurology
2021

Pathogenic Variants in ABHD16A Cause a Novel Psychomotor Developmental Disorder With Spastic Paraplegia.

Frontiers in neurology
2021

Disease Severity and Motor Impairment Correlate With Health-Related Quality of Life in AP-4-Associated Hereditary Spastic Paraplegia.

Neurology. Genetics
2021

Final Exon Frameshift Biallelic PTPN23 Variants Are Associated with Microcephalic Complex Hereditary Spastic Paraplegia.

Brain sciences
2021

ATP1A1 de novo Mutation-Related Disorders: Clinical and Genetic Features.

Frontiers in pediatrics
2021

Homozygous TFG gene variants expanding the mutational and clinical spectrum of hereditary spastic paraplegia 57 and a review of literature.

Journal of human genetics
2021

Complex hereditary spastic paraplegia associated with episodic visual loss caused by ACO2 variants.

Human genome variation
2020

Defining the clinical, molecular and imaging spectrum of adaptor protein complex 4-associated hereditary spastic paraplegia.

Brain : a journal of neurology
2020

Novel CAPN1 mutations extend the phenotypic heterogeneity in combined spastic paraplegia and ataxia.

Annals of clinical and translational neurology
2020

Is NIPA1-associated hereditary spastic paraplegia always 'pure'? Further evidence of motor neurone disease and epilepsy as rare manifestations.

Neurogenetics
2019

Mutations in PCYT2 disrupt etherlipid biosynthesis and cause a complex hereditary spastic paraplegia.

Brain : a journal of neurology
2019

Generation and characterization of six human induced pluripotent stem cell lines (iPSC) from three families with AP4B1-associated hereditary spastic paraplegia (SPG47).

Stem cell research
2019

Hereditary spastic paraplegia and prominent sensorial involvement: think MAG mutations!

Annals of clinical and translational neurology
2019

Defining the clinical-genetic and neuroradiological features in SPG54: description of eight additional cases and nine novel DDHD2 variants.

Journal of neurology
2019

FARS2 Causing Complex Hereditary Spastic Paraplegia With Dysphonia: Expanding the Disease Spectrum.

Journal of child neurology
2019

Re: Comments on "Pure or Complex Hereditary Spastic Paraplegia Type 4?": The Authors Respond.

Journal of clinical neurology (Seoul, Korea)
2019

Pure or Complex Hereditary Spastic Paraplegia Type 4?

Journal of clinical neurology (Seoul, Korea)
2019

SLC2A1 mutations are a rare cause of pediatric-onset hereditary spastic paraplegia.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2018

GPT2 mutations cause developmental encephalopathy with microcephaly and features of complicated hereditary spastic paraplegia.

Clinical genetics
2018

Functional Contribution of the Spastic Paraplegia-Related Triglyceride Hydrolase DDHD2 to the Formation and Content of Lipid Droplets.

Biochemistry
2017

New genetic causes for complex hereditary spastic paraplegia.

Journal of the neurological sciences
2017

NT5C2 novel splicing variant expands the phenotypic spectrum of Spastic Paraplegia (SPG45): case report of a new member of thin corpus callosum SPG-Subgroup.

BMC medical genetics
2017

Parkinsonian-Pyramidal syndromes: A systematic review.

Parkinsonism & related disorders
2016

Severe axonal neuropathy is a late manifestation of SPG11.

Journal of neurology
2016

Genetic and phenotypic characterization of complex hereditary spastic paraplegia.

Brain : a journal of neurology
2016

Three cases of Troyer syndrome in two families of Filipino descent.

American journal of medical genetics. Part A
2016

GSK3ß-dependent dysregulation of neurodevelopment in SPG11-patient induced pluripotent stem cell model.

Annals of neurology
2015

Alteration of ornithine metabolism leads to dominant and recessive hereditary spastic paraplegia.

Brain : a journal of neurology
2015

Recurrent null mutation in SPG20 leads to Troyer syndrome.

Molecular and cellular probes

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Paraplegia espástica hereditária complexa.

É de uma associação que acompanha esta doença? Fale com a gente →

Doença com base genética

Um médico geneticista pode ajudar no diagnóstico de Paraplegia espástica hereditária complexa e no aconselhamento genético da família.

Vai consultar um especialista? Confirme o registro dele no conselho.
Conselhos e sociedades

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Perguntas frequentes

O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu

Respostas geradas por IA a partir das fontes citadas

É uma condição de origem genética caracterizada por fraqueza e rigidez muscular nas pernas, inserida em um quadro neurológico mais abrangente. Ela é classificada nos catálogos internacionais de doenças raras como um grupo de fenótipos.

Referências

Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete

Citar este verbete

Raras. (s.d.). Paraplegia espástica hereditária complexa. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/paraplegia-espastica-hereditaria-complexa

Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Paraplegia espástica hereditária complexa

ORPHA:102013 · MONDO:0015150
MedGen
UMLS
C0393556
EuropePMC
Wikidata
Papers 10a

📋 Origem dos dados

Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.

Doença rara (ontologia)
fonte: Orphanet
Identificador unificado
fonte: MONDO
Dado público estruturado
fonte: Wikidata
Rara